Phuc Félix Nguyen‐Tan

Author

Centre Hospitalier de l’Université de Montréal

Also Known As

Loren K. Mell, Nguyen-Tan, Phuc Felix, P. Felix Nguyen-Tan, P. Nguyen-Tan, P.F. Nguyen-Tan, Phuc F Nguyen-Tan, Phuc F. Nguyen-Tân, Phuc Felix Nguyen-Tan, Phuc Felix Nguyen-Tân, Phuc Felix Nguyen‐Tan

103

Publications

11.1K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier de l’Université de Montréal Hôpital Notre-Dame Université de Montréal The University of Texas MD Anderson Cancer Center NRG Oncology

About

Phuc Félix Nguyen‐Tan is an author at Centre Hospitalier de l’Université de Montréal specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	30	2K
2	Health Sciences	19	20	1.6K
3	Public Health	4	4	146
4	Epidemiology	4	4	146
5	Biostatistics	2	2	692

Phuc Félix Nguyen‐Tan

Publications

10.9K

Citations

H-Index

Page 1

	Year	Citations
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer K. Kian Ang, Jonathan Harris, Richard Wheeler, New England Journal of Medicine	2010	6.4K
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522 K. Kian Ang, Qiang Zhang, David I. Rosenthal, Journal of Clinical Oncology	2014	821
Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma Carole Fakhry, Qiang Zhang, Phuc Félix Nguyen‐Tan, Journal of Clinical Oncology	2014	541
Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer Martin Vallières, Emily Kay‐Rivest, Léo Jean Perrin, Scientific Reports Tumour Image IntensityDiagnostic ImagingTumour FailureOncologyBiostatistics	2017	534
Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity Phuc Félix Nguyen‐Tan, Qiang Zhang, K. Kian Ang, Journal of Clinical Oncology	2014	461
Institutional Clinical Trial Accrual Volume and Survival of Patients With Head and Neck Cancer Evan Wuthrick, Qiang Zhang, Mitchell Machtay, Journal of Clinical Oncology	2014	245
A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC). K. Kian Ang, Q. E. Zhang, David I. Rosenthal, Journal of Clinical Oncology Rtog 0522Radiation MedicineOncologyMetronomic TherapyNeck Oncology	2011	181
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer Carole Fakhry, Qiang Zhang, Phuc Félix Nguyen‐Tan, Journal of Clinical Oncology Progression-free SurvivalSurgical OncologyCancer ManagementPrognosisOropharyngeal Cancer	2017	158
Treatment results and prognostic factors of advanced T3–4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience Phuc Félix Nguyen‐Tan, Quynh‐Thu Le, Jeanne-Marie Quivey, International Journal of Radiation OncologyBiologyPhysics Prognostic FactorsSurgical OncologyMedicineStanford University HospitalPathology	2001	99
Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy Canhua Xiao, Alexandra L. Hanlon, Qiang Zhang, Oral Oncology Neuro-oncologyConcurrent ChemoradiotherapyNeck CancerMedicineNasopharyngeal Cancer	2012	98

Page 1